deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT02433977

The Effects of NOx and Conjugated Linoleic Acid on Asthmatics (NICLA)

A Proof of Concept Study to Determine the Effects of NOX and Conjugated Linoleic Acid on Asthmatics

Sponsor: Gladwin, Mark, MD

Conditions Asthma
Interventions Conjugated Linolenic Acid Sodium Nitrate Sodium Nitrite
Updated 17 times since 2017 Last updated: Apr 5, 2021 Started: Sep 30, 2015 Primary completion: Nov 30, 2019 Completion: Nov 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02433977, this PHASE2 trial focuses on Asthma and remains completed. Sponsored by Gladwin, Mark, MD, it has been updated 17 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Jul 2017 · 4 months · monthly snapshot~Jul 2017 – ~Mar 2018 · 8 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Nov 2018 · 4 months · monthly snapshot~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshot~Jan 2019 – ~Dec 2019 · 11 months · monthly snapshot~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Dec 2022 · 19 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. May 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 12 earlier versions

  1. Apr 2021 — May 2021 [monthly]

    Completed PHASE2

  2. Jan 2021 — Apr 2021 [monthly]

    Completed PHASE2

  3. Dec 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  4. Jan 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  5. Nov 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  6. Jul 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  7. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  8. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  9. Jul 2017 — Mar 2018 [monthly]

    Recruiting PHASE2

  10. Mar 2017 — Jul 2017 [monthly]

    Recruiting PHASE2

  11. Feb 2017 — Mar 2017 [monthly]

    Recruiting PHASE2

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Gladwin, Mark, MD
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations